Stella E. Lee

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Claus Bachert, Joseph K. Han, Martin Desrosiers et al. · The Lancet · 2019 · 1.5K citations

Medicine, Immunology, Otolaryngology +10

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

Philippe Gevaert, Theodore A. Omachi, Jonathan Corren et al. · Journal of Allergy and Clinical Immunology · 2020 · 697 citations · Full text

Medicine, Otolaryngology, Pharmacotherapy +17

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt et al. · Science · 2021 · 599 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Sarah K. Wise, Sandra Y. Lin, Elina Toskala et al. · International Forum of Allergy & Rhinology · 2018 · 549 citations · Full text

Life Sciences, Immunology, Otolaryngology +17

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management

Claus Bachert, J Han, Martin Wagenmann et al. · Journal of Allergy and Clinical Immunology · 2020 · 348 citations

Medicine, Otolaryngology, Surgery +13